EUVIMEDEUVIMED entdecken
Crossref

LXR inhibitor SR9243-loaded immunoliposomes modulate lipid metabolism and stemness in colorectal cancer cells

Hassan Dianat-Moghadam, Soheil Abbasspour-Ravasjani, Hamed Hamishehkar, Reza Rahbarghazi, Mahammad Nouri

Medical Oncology · 2023

DOI: 10.1007/s12032-023-02027-4 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Medical Oncology, 2023. Verfasst von Hassan Dianat-Moghadam und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Biotechnology, Faculty of Advanced Medical Sciences, Tabriz University of Medical Sciences, Tabriz, Iran. dianat.h@med.mui.ac.i…. Hauptthemen laut MEDLINE: Liposomes, Colorectal Neoplasms. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 43 Literaturangaben. Gefördert von: Tabriz University of Medical Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LiposomesColorectal NeoplasmsHumansCell Line, TumorLipid MetabolismNeoplastic Stem CellsAC133 AntigenSulfonamides

Stichwörter der Autor:innen

Cancer metabolismClonogenicityLXRROSStemness

Substanzen

LiposomesAC133 AntigenSR9243Sulfonamides

Autor:innen und Institutionen

  • Department of Medical Biotechnology, Faculty of Advanced Medical Sciences, Tabriz University of Medical Sciences, Tabriz, Iran. dianat.h@med.mui.ac.ir.
  • Department of Genetics and Molecular Biology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran. dianat.h@med.mui.ac.ir.
  • Stem Cell Research Center, Tabriz University of Medical Sciences, Tabriz, Iran. dianat.h@med.mui.ac.ir.
  • Drug Applied Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
  • Stem Cell Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
  • Department of Medical Biotechnology, Faculty of Advanced Medical Sciences, Tabriz University of Medical Sciences, Tabriz, Iran. Nourimd@yahoo.com.

Förderung

  • Tabriz University of Medical Sciences

Zitieren

APA

Dianat-Moghadam, H., Abbasspour-Ravasjani, S., Hamishehkar, H., Rahbarghazi, R., & Nouri, M. (2023). LXR inhibitor SR9243-loaded immunoliposomes modulate lipid metabolism and stemness in colorectal cancer cells. Medical Oncology. https://doi.org/10.1007/s12032-023-02027-4

Vancouver

Dianat-Moghadam H, Abbasspour-Ravasjani S, Hamishehkar H, Rahbarghazi R, Nouri M. LXR inhibitor SR9243-loaded immunoliposomes modulate lipid metabolism and stemness in colorectal cancer cells. Medical Oncology. 2023. doi:10.1007/s12032-023-02027-4

BibTeX
@article{DianatMoghadam2023,
  author = {Dianat-Moghadam, Hassan and Abbasspour-Ravasjani, Soheil and Hamishehkar, Hamed and Rahbarghazi, Reza and Nouri, Mahammad},
  title = {LXR inhibitor SR9243-loaded immunoliposomes modulate lipid metabolism and stemness in colorectal cancer cells},
  journal = {Medical Oncology},
  year = {2023},
  doi = {10.1007/s12032-023-02027-4}
}
Kostenlos starten →